|
Why is not Ukrain approved yet in Austria/EU? |
98.57% |
|
Ukrain (NSC-631570) in the treatment of pancreas cancer. |
95.00% |
|
Reducing malignant ascites accumulation by repeated intraperitoneal administrations of a Viscum album extract. |
95.00% |
|
Study of the effects of vinpocetin on cognitive functions |
90.00% |
|
Clinical Investigations on Ukrain |
90.00% |
|
Effects of CANELIM capsule drug-contained serum on viscoelasticity |
90.00% |
|
Ukrain - a new cancer cure? A systematic review of randomised clinical trials. |
90.00% |
|
Retrospective study of Ukrain treatment in 203 patients with advanced-stage tumors |
90.00% |
|
Hibiscus sabdariffa L. Tea (Tisane) Lowers Blood Pressure in Prehypertensive and Mildly Hypertensive Adults |
90.00% |
|
Boswellia serrata acts on cerebral edema in patients irradiated for brain tumors: a prospective, randomized, placebo-controlled, |
90.00% |
|
Debate in Lancet about setting up a phase II trial on Ukrain in England |
90.00% |
|
Medicinal plants and cancer chemoprevention. |
90.00% |
|
WHO’S AFRAID OF A CURE FOR CANCER? - The struggle for an alternative cancer drug |
90.00% |
|
Mistletoe therapy in oncology |
90.00% |
|
Artemisinin derivates in the treatment of Cancer |
90.00% |
|
Prospective controlled cohort studies on long-term therapy of cervical cancer patients with a mistletoe preparation (Iscador). |
90.00% |
|
Curcumin |
85.00% |
|
NSC-631570 (Ukrain) in the palliative treatment of pancreatic cancer. Results of a phase II trial |
85.00% |
|
Hypericine |
83.33% |
|
Mistletoe Therapy in Cancer |
83.33% |
|
Complementary and alternative medicines taken by cancer patients |
80.00% |
|
Inhibitory effect of ginsenoside Rg3 combined with cyclophosphamide on growth and angiogenesis of ovarian cancer. |
80.00% |
|
An orally active Amazonian plant extract (BIRM) inhibits prostate cancer growth and metastasis. |
80.00% |
|
Can Chinese Medicine Be Used for Prevention of Corona Virus Disease 2019 (COVID-19)? A Review of Historical Classics, Research Evidence and Current Prevention Programs |
80.00% |
|
Enhanced radiation sensitivity and radiation recall dermatitis (RRD) after hypericin therapy – case report and review of literat |
80.00% |
|
Prospective controlled cohort studies on long-term therapy of breast cancer patients with a mistletoe preparation (Iscador) |
80.00% |
|
Synergistic activity of PHY906 with capecitabine in pancreatic carcinoma. |
80.00% |
|
Double-blind, placebo-controlled, randomised study of single dose effects of ADAPT-232 on cognitive functions. |
80.00% |
|
A mechanistic study on altered pharmacokinetics of irinotecan by St. John's wort |
80.00% |
|
Ukrain: Debated Subjects |
80.00% |
|
Ukrain Debate 1: What is the active Substance of Ukrain? |
80.00% |
|
Modified citrus pectin anti-metastatic properties: one bullet, multiple targets. |
80.00% |
|
Dramatic prostate-specific antigen response with activated hemicellulose compound in metastatic castration-resistant prostate ca |
80.00% |
|
In vitro screening for the tumoricidal properties of international medicinal herbs |
80.00% |
|
Resveratrol |
80.00% |
|
Comparison of chemotherapy and X-ray therapy with Ukrain monotherapy for colorectal cancer |
80.00% |
|
Impact of complementary treatment of breast cancer patients with standardized mistletoe extract during aftercare: a controlled m |
80.00% |
|
Individual Patient Data Meta-analysis of Survival and Psychosomatic Self-regulation from Published Prospective Controlled Cohort |
80.00% |
|
A lipoxygenase inhibitor in breast cancer brain metastases. |
80.00% |
|
Comparative evaluation of the complex treatment of rectal cancer patients (chemotherapy and X-ray therapy, Ukrain monotherapy) |
80.00% |
|
Potential therapeutic efficacy of Ukrain (NSC 631570) in AIDS patients with Kaposi's sarcoma |
80.00% |
|
Ukrain therapy of recurrent breast cancer with lung metastases (case report) |
80.00% |
|
Artesunate combined with vinorelbine plus cisplatin in treatment of advanced non-small cell lung cancer: a randomized controlled |
80.00% |
|
The clinical efficacy of adjuvant systemic chemotherapy with gemcitabine and NSC-631570 in advanced pancreatic cancer. |
75.00% |
|
Ukrain treatment in a patient with breast carcinoma |
70.00% |
|
Ukrain treatment in carcinoma of the oesophagus (case report) |
70.00% |
|
Inhibitory effect of modified citrus pectin on liver metastases in a mouse colon cancer model. |
70.00% |
|
The inhibition of glioma growth in vitro and in vivo by a chitosan/ellagic acid composite biomaterial. |
70.00% |
|
Green Tea extract |
70.00% |
|
Efficacy of ukrain in the treatment of pancreatic cancer. |
70.00% |
|
Hibiscus as medical herb Hibiscus sabdariffa L. |
70.00% |
|
A Phase I/IIA, Multicenter, Double-Blind, Randomized, Placebo-Controlled, Crossover, Dose-Escalation, Safety Study of the Chemot |
70.00% |
|
Pilot study of huachansu in patients with hepatocellular carcinoma, nonsmall-cell lung cancer, or pancreatic cancer. |
70.00% |
|
Effects of artemisinin and its derivatives on growth inhibition and apoptosis of oral cancer cells. |
70.00% |
|
Medical Cannabis Compounds |
70.00% |
|
Garlic, or Allium sativum: a review of its potential use as an anti-cancer agent. |
70.00% |
|
Safety and Efficacy of Tien-Hsien Liquid Practical in Patients with Refractory Metastatic Breast Cancer: A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase IIa Trial |
70.00% |
|
Preliminary results of individual therapy of chronic hepatitis C by Ukrain and interferon-alpha. |
70.00% |
|
Influence of Hypericum perforatum extract and its single compounds on amyloid-beta mediated toxicity in microglial cells. |
70.00% |
|
Comparative evaluation of the efficiency of various Ukrain doses in the combined treatment of breast cancer. |
65.00% |
|
Evaluation of Ukrain as an immunostimulant in patients with various carcinomas. |
63.33% |
|
Chelidonium majus L. (Ukrain) in the treatment of cancer patients. |
63.33% |
|
Ukrain |
62.22% |
|
Gallic acid, a major component of Toona sinensis leaf extracts, contains a ROS-mediated anti-cancer activity in human prostate |
60.00% |
|
Pycnogenol may alleviate adverse effects in oncologic treatment. |
60.00% |
|
Inhibition of spontaneous metastasis in a rat prostate cancer model by oral administration of modified citrus pectin. |
60.00% |
|
Boswellia |
60.00% |
|
Ukrain both as an anti cancer and immunoregulatory agent |
60.00% |
|
Is there a role for herbal medicine in the treatment of pancreatic cancer?. Highlights from the "44th ASCO Annual Meeting". |
60.00% |
|
Is there a standard of care for the management of advanced pancreatic cancer?. Highlights from the Gastrointestinal Cancers Symp |
60.00% |
|
Combined therapy with Ukrain and chemotherapy in ovarian cancer (case report) |
60.00% |
|
The effects of thiophosphoric acid (Ukrain) on cervical cancer, stage IB bulky |
60.00% |
|
Ukrain therapy of stage T1N0M0 bladder cancer patients |
60.00% |
|
Ukrain treatment in carcinoma of the cervix (case report) |
60.00% |
|
Biophysiological effects of Ukrain therapy in a patient with breast cancer (case report) |
60.00% |
|
New biochemical mechanisms of the anticancer effect of Ukrain in the treatment of cancer of the urinary bladder |
60.00% |
|
Beta-solamarine: tumor inhibitor isolated from Solanum dulcamara. |
60.00% |
|
Chinese herbal medicine for COVID-19: Current evidence with systematic review and meta-analysis |
60.00% |
|
Lymphocyte subsets in patients with lung cancer treated with thiophosphoric acid |
55.00% |
|
Propolis Extract (Bio 30) Suppresses the Growth of Human Neurofibromatosis (NF) Tumor Xenografts in Mice |
55.00% |
|
Ukrain treatment in a patient with metastatic renal cell carcinoma extending to the vena cava inferior. |
50.00% |
|
Results of Ukrain monotherapy of prostate cancer |
50.00% |
|
Ukrain with chemotherapy in malignant melanoma (case report) |
50.00% |
|
Ukrain in the treatment of urethral recurrent carcinoma (case report) |
50.00% |
|
Annonacin, a mono-tetrahydrofuran acetogenin, arrests cancer cells at the G1 phase and causes cytotoxicity in a Bax- and caspase |
50.00% |
|
Adjuvant simultaneous mistletoe chemotherapy in breast cancer--influence on immunological parameters, quality of life and tolera |
50.00% |
|
Ukrain treatment in a patient with non-seminomatous germ-cell tumour of testis (case report) |
50.00% |
|
Immunologic effector mechanisms of a standardized mistletoe extract on the function of human monocytes and lymphocytes in vitro, |
50.00% |
|
Adjuvante simultane Mistel-/Chemotherapie bei Mammakarzinom – Einfluss auf Immunparameter, Lebensqualität und Verträglichkeit |
50.00% |
|
Randomized and non-randomized prospective controlled cohort studies in matched pair design for the long-term therapy of corpus u |
50.00% |
|
A Phase I study of the safety of the nutritional supplement, active hexose correlated compound, AHCC, in healthy volunteers. |
50.00% |
|
Comparative evaluation of blood plasma and tumor tissue amino acid pool in radiation or neoadjuvant preoperative therapies.... |
50.00% |
|
Reconciling model predictions with low reported cases of COVID-19 in Sub-Saharan Africa: insights from Madagascar |
50.00% |
|
Die Rolle von Boswellia-Säuren in der Therapie maligner Gliome: Methodische Mängel |
50.00% |
|
Ukrain therapy in a frontal anaplastic grade III astrocytoma (case report) |
40.00% |
|
Mistletoe in conventional oncological practice: exemplary cases. |
40.00% |
|
Ukrain treatment of a patient with retroperitoneal synovial sarcoma. |
35.00% |
|
Clinical aspects of cancer treatment and new biochemical mechanisms of the drug Ukrain. |
20.00% |
|
Cancer Treatments |
20.00% |
|
Mistletoe as a treatment for cancer. Has no proved benefit, and can cause harm |
20.00% |
